Cadrenal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022
Market Capitalization	7	10	-
Market Cap Growth	-40.47%	-	-
Enterprise Value	1	1	1
PE Ratio	-	-1.15	-
PB Ratio	1.16	1.25	-
P/FCF Ratio	-2.47	-2.73	-
P/OCF Ratio	-2.47	-2.73	-
EV/EBITDA Ratio	-0.66	-0.15	-0.09
EV/EBIT Ratio	-0.66	-0.15	-0.09
EV/FCF Ratio	-0.81	-0.35	-0.50
Debt / Equity Ratio	0.00	0.00	-0.12
Debt / EBITDA Ratio	0.00	0.00	-0.10
Debt / FCF Ratio	0.00	-0.01	-0.53
Quick Ratio	7.67	10.16	0.02
Current Ratio	8.21	10.27	0.55
Interest Coverage	-	-487.69	-61.68
Return on Equity (ROE)	-75.10%	-141.20%	-
Return on Assets (ROA)	-68.20%	-129.20%	-
Return on Capital (ROIC)	-83.58%	-98.95%	55.02%
Earnings Yield	-67.28%	-86.73%	-
FCF Yield	-54.89%	-36.67%	-
Buyback Yield / Dilution	-48.61%	-70.99%	-
Total Shareholder Return	-48.61%	-70.99%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).